Detect Novel Virus | Detect SARS-COV-2 and Diagnose COVID-19 | Detect and Monitor Respiratory Infections | Detect Patient Immunity | ||
---|---|---|---|---|---|
Testing Needs | Metagenomics (NGS) | PCR/qPCR | Amplicon (NGS) Illumina COVIDSeq Test | Target Enrichment (NGS) | Serology |
Speed & Turnaround Time | |||||
Scalable & Cost-Effective | |||||
Identify Novel Pathogens | |||||
Track Transmission | |||||
Unaffected by Mutations | |||||
Identify Co-Infections & Complex Disease | |||||
Detect Antimicrobial Resistance |
Adequately meets laboratory testing needs
Partially meets laboratory testing needs
Comprehensively sequence all organisms in a given sample and identify novel pathogens such as coronaviruses. This NGS method can help accelerate outbreak investigations and support development of new laboratory tests.
Detect and characterize coronaviruses, flu viruses, and other pathogenic respiratory tract organisms, as well as associated antimicrobial resistance alleles. These insights can help researchers monitor respiratory infections and optimize infection control strategies. This method captures genomic regions of interest via hybridization to target-specific probes.
Detect the presence of the SARS-CoV-2 coronavirus by sequencing specific regions of the viral genome. This method involves analyzing genomic regions of interest with ultra-deep sequencing of PCR amplicons.
The COVID-19 pandemic has underscored the need for tools to detect and monitor emerging pathogens like SARS-CoV-2. Next-generation sequencing led to the initial detection of the coronavirus, and is accelerating test and vaccine development.
Access WebinarLearn about the broad applicability of next-generation sequencing for responding to the COVID-19 pandemic, from initial detection and characterization of the novel coronavirus to monitoring, surveillance, and diagnostic detection.
Access WebinarFormer U.S. FDA Commissioner Dr. Scott Gottlieb discusses the role and benefits of genomics and sequencing technologies in COVID-19 surveillance.
Access WebinarThe partnership aims to expand NGS adoption for clinical infectious disease testing. It has been accelerated to provide improved support to customers globally performing NGS for surveillance purposes during the COVID-19 pandemic.
Read ArticleRapid target enrichment sequencing for broad detection of respiratory pathogens (including SARS-CoV-2, flu viruses, and fungi) and associated antimicrobial resistance alleles.
Read Application NoteA rapid target enrichment sequencing workflow for highly sensitive detection and characterization of coronaviruses, flu viruses, and other respiratory viruses.
Read Application NoteMiniSeq Rapid reagents reduce sequencing run times to < 5 hours, allowing fast detection of coronaviruses and other respiratory viruses.
Read Application NotePhil Febbo, MD, Chief Medical Officer of Illumina, discusses five main ways in which next-generation sequencing-based surveillance is used to fight the SARS-CoV-2 coronavirus.
Read ArticleIn keeping with recommendations from the United States CDC and World Health Organization, Illumina recommends this procedure for decontaminating NGS instruments suspected or known to have come in contact with the novel coronavirus SARS-CoV-2 (2019-nCoV).
Read BulletinUse of ammonia-based cleaners and sanitizing products (frequently utilized to clean labs during the COVID-19 pandemic) in proximity to sequencing run setup can result in decreased sequencing run performance metrics. View tips on how to avoid these issues.
Read BulletinIn a groundbreaking initiative, public health labs use Illumina technology to sequence the viral genomes of all positive COVID-19 tests in Australia and track COVID-19 across the country, rather than state by state.
Read ArticleIllumina recently joined the NIH’s Rapid Acceleration of Diagnostics initiative and is offering a COVID testing service to help make SARS-CoV-2 testing more widely available.
Read ArticleA collaborative environment leveraging BaseSpace Correlation Engine helps COVID-19 researchers validate hypotheses around important pathways, biomarkers, and potential drug candidate leads.
Learn MoreRapid library preparation from a broad range of sample types for studying the coding and non-coding transcriptome with unparalleled study flexibility.
The stand-alone Illumina Ribo-Zero Plus kit allows for ribosomal RNA removal in human, mouse, rat, and bacterial samples.
Groundbreaking benchtop sequencers allow you to explore new science across a variety of current and emerging applications, with higher efficiency and fewer restraints.
The iSeq 100 system leverages the speed and affordability of complementary metal-oxide-semiconductor (CMOS) technology and the accuracy of sequencing by synthesis (SBS) chemistry.
View ProductThe MiSeq benchtop sequencer enables targeted and microbial genome applications, with high-quality sequencing, simple data analysis, and cloud storage.
View ProductIllumina RNA Prep with Enrichment is the fastest and most flexible targeted sequencing solution for RNA in the Illumina library prep portfolio.
View ProductComprehensively sequence all organisms present in a given complex sample. Identify novel pathogens or detect microbial abundance in various environments.
Learn MoreSequence exomes or large numbers of genes (e.g. > 50 genes) using a robust hybridization-based enrichment approach that supports a wide range of sample types.
Learn MoreSimultaneously assess a few to hundreds of genes or targets in a single run with this highly targeted multiplex PCR-based sequencing approach.
Learn More